237 related articles for article (PubMed ID: 1317224)
1. Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis.
Weber MF; Andrassy K; Pullig O; Koderisch J; Netzer K
J Am Soc Nephrol; 1992 Jan; 2(7):1227-34. PubMed ID: 1317224
[TBL] [Abstract][Full Text] [Related]
2. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides.
Savige JA; Gallicchio M; Georgiou T; Davies DJ
Clin Exp Immunol; 1990 Nov; 82(2):238-43. PubMed ID: 1978702
[TBL] [Abstract][Full Text] [Related]
3. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
[TBL] [Abstract][Full Text] [Related]
4. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
5. Goodpasture's disease: a report of ten cases and a review of the literature.
Dammacco F; Battaglia S; Gesualdo L; Racanelli V
Autoimmun Rev; 2013 Sep; 12(11):1101-8. PubMed ID: 23806563
[TBL] [Abstract][Full Text] [Related]
6. Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis.
Bosch X; Mirapeix E; Font J; Cervera R; Ingelmo M; Khamashta MA; Revert L; Hughes GR; Urbano-Márquez A
Am J Kidney Dis; 1992 Sep; 20(3):231-9. PubMed ID: 1325737
[TBL] [Abstract][Full Text] [Related]
7. Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes.
Westman KW; Bygren PG; Eilert I; Wiik A; Wieslander J
Nephrol Dial Transplant; 1997 Sep; 12(9):1863-8. PubMed ID: 9306336
[TBL] [Abstract][Full Text] [Related]
8. An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA).
Rasmussen N; Sjölin C; Isaksson B; Bygren P; Wieslander J
J Immunol Methods; 1990 Feb; 127(1):139-45. PubMed ID: 2156937
[TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
10. Comparison of anti-GBM antibodies in sera with or without ANCA.
Hellmark T; Niles JL; Collins AB; McCluskey RT; Brunmark C
J Am Soc Nephrol; 1997 Mar; 8(3):376-85. PubMed ID: 9071706
[TBL] [Abstract][Full Text] [Related]
11. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
12. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L
Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
[TBL] [Abstract][Full Text] [Related]
13. Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3.
Badakere SS; Pradhan VD; Almeida AF; Pawar AR
J Fluoresc; 2004 Jul; 14(4):459-63. PubMed ID: 15617388
[TBL] [Abstract][Full Text] [Related]
14. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.
Kallenberg CG; Mulder AH; Tervaert JW
Am J Med; 1992 Dec; 93(6):675-82. PubMed ID: 1466365
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.
Savige JA; Chang L; Wilson D; Buchanan RR
Rheumatol Int; 1996; 16(3):109-14. PubMed ID: 8893375
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of anti-neutrophil cytoplasmic antibody and pathogenetic role of adhesion molecules for Wegener's granulomatosis].
Takizawa M
Hokkaido Igaku Zasshi; 1996 Jul; 71(4):517-29. PubMed ID: 8809575
[TBL] [Abstract][Full Text] [Related]
18. Determination of anti-neutrophil cytoplasm antibodies (ANCA) specificity by immunofluorescence on chronic myelocytic leukemia cells.
Chevailler A; Noel LH; Renier G; Gardembas-Pain M; Subra JF; Nusbaum P; Hurez D; Lesavre P
J Immunol Methods; 1992 Feb; 147(1):101-9. PubMed ID: 1311734
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcome of Chinese patients with both antineutrophil cytoplasmic antibody and antiglomerular basement membrane antibodies.
Zhao J; Yang R; Cui Z; Chen M; Zhao MH; Wang HY
Nephron Clin Pract; 2007; 107(2):c56-62. PubMed ID: 17804912
[TBL] [Abstract][Full Text] [Related]
20. A case of simultaneous, biopsy-proven, classic, ANCA-positive Wegener's granulomatosis and anti-GBM disease, but without detectable circulating anti-GBM antibodies.
Gmurczyk A; Ahya SN; Goldschmidt R; Kim G; Ho LT; Nash K
ScientificWorldJournal; 2010 Jun; 10():1078-83. PubMed ID: 20563530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
